Hyperion DeFi Inc.
Organization details
- Legal name
- Hyperion DeFi Inc.
- Former names
- Eyenovia, INC.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Dallas
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HYPD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001682639
- EIN
- 47-1178401
Board of directors
-
Charles E. Mather IV · DirectorSince 2023
-
Ellen R. Strahlman · DirectorSince 2023
-
Happy David Walters · DirectorSince 2025
-
Hyunsu Jung · Director · See RemarksSince 2025
-
Michael M. Rowe · Director · Chief Executive OfficerSince 2023
-
Michael S. Geltzeiler · DirectorSince 2023
-
Rachel Jacobson · DirectorSince 2023
-
Ram Palanki · DirectorSince 2023
-
Tsontcho Ianchulev · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.3%
-
94.3%
-
97.8%
-
98.5%
-
98.7%
Board connections
1 of this board's directors also sit on 1 other board.
- via Ellen R. Strahlman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $641,047
- 13 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 29, 2026 | Knox David R. Officer (Chief Financial Officer) | Shares withheld for tax | −19,563 | — | — |
| Aug 16, 2026 | Hyunsu Jung Director, Officer (See Remarks) | Shares withheld for tax | −40,000 | — | — |
| Jun 30, 2026 | Michael S. Geltzeiler Director | Grant or award | +58,917 | — | — |
| Jun 30, 2026 | Rachel Jacobson Director | Grant or award | +58,917 | — | — |
| Jun 30, 2026 | Ellen R. Strahlman Director | Grant or award | +58,917 | — | — |
| Jun 30, 2026 | Happy David Walters Director | Grant or award | +58,917 | — | — |
| Jun 2, 2026 | Hyunsu Jung Director, Officer (See Remarks) | Open-market purchase | +500 | $3.64 | $1,820 |
| Jun 2, 2026 | Hyunsu Jung Director, Officer (See Remarks) | Open-market purchase | +500 | $3.68 | $1,840 |
| Jun 1, 2026 | Hyunsu Jung Director, Officer (See Remarks) | Open-market purchase | +5,000 | $3.66 | $18,300 |
| Jun 1, 2026 | Hyunsu Jung Director, Officer (See Remarks) | Open-market purchase | +2,000 | $3.81 | $7,620 |
| May 27, 2026 | Hyunsu Jung Director, Officer (See Remarks) | Shares withheld for tax | −40,000 | — | — |
| Mar 30, 2026 | Knox David R. Officer (Chief Financial Officer) | Shares withheld for tax | −20,831 | — | — |
| Jan 12, 2026 | Rubenstein Robert Officer (General Counsel) | Grant or award | +75,000 | — | — |
| Dec 31, 2025 | Knox David R. Officer (Chief Financial Officer) | Open-market purchase | +27,950 | $3.59 | $100,341 |
| Dec 29, 2025 | Hyunsu Jung Director, Officer (See Remarks) | Shares withheld for tax | −82,324 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Hyperion DeFi Inc.
Who is the CEO of Hyperion DeFi Inc.?
Michael M. Rowe is Hyperion DeFi Inc.'s CHIEF EXECUTIVE OFFICER.
How many directors are on Hyperion DeFi Inc.'s board?
Hyperion DeFi Inc.'s board has 9 directors: Charles E. Mather IV, Ellen R. Strahlman, Happy David Walters, Hyunsu Jung, Michael M. Rowe, Michael S. Geltzeiler, Rachel Jacobson, Ram Palanki and Tsontcho Ianchulev.
Are Hyperion DeFi Inc. insiders buying or selling shares?
Over the last 12 months, Hyperion DeFi Inc. insiders bought $641,047 of shares in 13 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="hyperion-defi-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.